JP2004513074A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513074A5 JP2004513074A5 JP2002509771A JP2002509771A JP2004513074A5 JP 2004513074 A5 JP2004513074 A5 JP 2004513074A5 JP 2002509771 A JP2002509771 A JP 2002509771A JP 2002509771 A JP2002509771 A JP 2002509771A JP 2004513074 A5 JP2004513074 A5 JP 2004513074A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- tumor
- determined
- antibody
- ovarian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 description 15
- 239000012634 fragment Substances 0.000 description 7
- 206010061535 Ovarian neoplasm Diseases 0.000 description 5
- 208000023965 endometrium neoplasm Diseases 0.000 description 4
- 239000013610 patient sample Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 239000000074 antisense oligonucleotide Substances 0.000 description 2
- 238000012230 antisense oligonucleotides Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00114788A EP1172654B1 (en) | 2000-07-10 | 2000-07-10 | Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors |
| EP00114788.3 | 2000-07-10 | ||
| PCT/EP2001/007924 WO2002004952A2 (en) | 2000-07-10 | 2001-07-10 | Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004513074A JP2004513074A (ja) | 2004-04-30 |
| JP2004513074A5 true JP2004513074A5 (cg-RX-API-DMAC7.html) | 2008-09-04 |
| JP5165827B2 JP5165827B2 (ja) | 2013-03-21 |
Family
ID=8169210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002509771A Expired - Fee Related JP5165827B2 (ja) | 2000-07-10 | 2001-07-10 | 卵巣腫瘍および子宮内膜腫瘍に対するl1接着分子に基づく卵巣腫瘍または子宮内膜腫瘍の検出方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7618785B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1172654B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5165827B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1479871A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE377192T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001285820A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2415364C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60036935T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2296586T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002004952A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2296586T3 (es) * | 2000-07-10 | 2008-05-01 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio. |
| US6852874B2 (en) | 2000-10-02 | 2005-02-08 | The Scripps Research Institute | Second cycle asymmetric dihydroxylation reaction |
| EP1623995A1 (en) | 2004-08-06 | 2006-02-08 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Inhibitors of L1 and ADAM10 for the treatment of carcinomas |
| WO2007114550A1 (en) * | 2006-04-03 | 2007-10-11 | Korea Research Institute Of Bioscience And Biotechnology | A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same |
| AU2007288620B2 (en) | 2006-08-23 | 2012-08-30 | Korea Research Instititute Of Bioscience And Biotechnology | A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| WO2008151819A2 (en) * | 2007-06-15 | 2008-12-18 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Treatment of tumors using specific anti-l1 antibody |
| AU2008201871A1 (en) * | 2008-04-16 | 2009-11-26 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Inhibition of angiogenesis and tumor metastasis |
| KR20100060351A (ko) | 2008-11-27 | 2010-06-07 | 한국생명공학연구원 | L1cam의 활성 또는 발현을 억제하는 물질 및 항암제를포함하는 항암용 조성물 |
| KR101504039B1 (ko) * | 2012-11-16 | 2015-03-19 | 강원대학교산학협력단 | 인간 및 마우스 l1cam 단백질에 특이적으로 결합하는 항체 및 이의 용도 |
| KR20250140647A (ko) * | 2020-08-03 | 2025-09-25 | 난트셀, 인크. | Il-15 초작용제에 대한 약물-특이적 약동학 검정 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939240A (en) * | 1983-03-04 | 1990-07-03 | Health Research, Inc. | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy |
| GB2339200B (en) * | 1998-06-06 | 2001-09-12 | Genostic Pharma Ltd | Genostics |
| ES2296586T3 (es) * | 2000-07-10 | 2008-05-01 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio. |
| US20020115065A1 (en) * | 2000-08-28 | 2002-08-22 | Ton Logtenberg | Differentially expressed epitopes and uses thereof |
| EP1399850A2 (en) * | 2001-02-21 | 2004-03-24 | The Board of Regents of The University of Oklahoma | Hla ligand database utilizing predictive algorithms and methods of making and using same |
-
2000
- 2000-07-10 ES ES00114788T patent/ES2296586T3/es not_active Expired - Lifetime
- 2000-07-10 EP EP00114788A patent/EP1172654B1/en not_active Expired - Lifetime
- 2000-07-10 DE DE60036935T patent/DE60036935T2/de not_active Expired - Lifetime
- 2000-07-10 AT AT00114788T patent/ATE377192T1/de active
-
2001
- 2001-07-10 EP EP01965101A patent/EP1386162A2/en not_active Withdrawn
- 2001-07-10 US US10/332,876 patent/US7618785B2/en not_active Expired - Fee Related
- 2001-07-10 JP JP2002509771A patent/JP5165827B2/ja not_active Expired - Fee Related
- 2001-07-10 CN CNA018125344A patent/CN1479871A/zh active Pending
- 2001-07-10 AU AU2001285820A patent/AU2001285820A1/en not_active Abandoned
- 2001-07-10 WO PCT/EP2001/007924 patent/WO2002004952A2/en not_active Ceased
- 2001-07-10 CA CA002415364A patent/CA2415364C/en not_active Expired - Fee Related
-
2007
- 2007-10-02 US US11/865,989 patent/US7670601B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Macanovic et al. | Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay | |
| Ahmed et al. | Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer | |
| US8329410B2 (en) | Method for diagnosing kidney disease comprising detecting the level of annexin A2 | |
| AU2014232155B2 (en) | SRM assay to indicate cancer therapy | |
| SG169395A1 (en) | Detection of cancer by elevated levels of bcl-2 | |
| Cho et al. | Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis | |
| JP2005531321A5 (cg-RX-API-DMAC7.html) | ||
| Lin et al. | Deep depletion of abundant serum proteins reveals low‐abundant proteins as potential biomarkers for human ovarian cancer | |
| JP2012509477A5 (cg-RX-API-DMAC7.html) | ||
| DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| JP2013524251A (ja) | 妊娠高血圧疾患のバイオマーカー | |
| WO2007082144A2 (en) | B7-h1 and survivin in cancer | |
| US20040219597A1 (en) | Use of soluble cytokeratin-1-fragments in diagnostics and therapy | |
| WO2012027631A2 (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| AU2017251859A1 (en) | SRM/MRM assay for subtyping lung histology | |
| Kulka et al. | Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR—a comparison with immunohistochemical and FISH results | |
| AU2015203904B2 (en) | SRM assay for PD-L1 | |
| JP2003524017A5 (cg-RX-API-DMAC7.html) | ||
| AU2017203160A1 (en) | Bcl-2-like protein 11 srm/mrm assay | |
| Huber et al. | Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer | |
| JP2004504327A5 (cg-RX-API-DMAC7.html) | ||
| Kim et al. | Expression of the HMGI (Y) gene in human colorectal cancer | |
| Sjöström | Predictive factors for response to chemotherapy in advanced breast cancer | |
| KR101096487B1 (ko) | 자폐증의 진단 | |
| EP1159614A4 (en) | DIAGNOSTIC METHOD FOR ASTHMA |